Feed ME
ME

23andMe Holding Co.

ME · NASDAQ

$0.61 N/A (+$0.61)
Analiza

AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.

Piotroski F-Score Weak
3/9
Valuation
-
N/A
EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A
Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A
Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A
ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A
Current ratio N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
63 /100
Moderate
Beta 1.20x
EPS volatility N/A
Profitable years N/A

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o ME
Online

O podjetju

23andMe Holding Co. is an American biotechnology company specializing in genetic testing and DNA analysis for personal genetic information and health insights. Their services enable individuals to obtain information about their genetic ancestry, predisposition to certain diseases, and health-related risk factors. The company also conducts research in the field of genetics and collaborates with pharmaceutical companies on the development of new drugs and therapies based on genetic data. Their platform is known for its high standard of privacy protection and transparency in the use of genetic data. 23andMe Holding Co. shares could be an interesting choice for investors looking for opportunities in genetic research and biotechnology.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Joseph Selsavage

Employees

560

Headquarters

South San Francisco

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.